Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V E Simmons

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
BMJ (Clinical Research Ed.)|July 11, 1992
Coronary vasospasm and sumatriptanW M Castle, V E Simmons
BMJ (Clinical Research Ed.)|August 1, 1992
Coronary vasospasm and sumatriptanD K Lloyd, A J Pilgrim, V E Simmons
European Journal of Neurology|June 2, 2007
Awareness of potential valvulopathy risk with pergolide and changes in clinical practice after label change: a survey among European neurologistsA Lledó, M A Dellva, I M Strombom, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
BMJ (Clinical Research Ed.)|July 11, 1992
Coronary vasospasm and sumatriptanW M Castle, V E Simmons
BMJ (Clinical Research Ed.)|August 1, 1992
Coronary vasospasm and sumatriptanD K Lloyd, A J Pilgrim, V E Simmons
European Journal of Neurology|June 2, 2007
Awareness of potential valvulopathy risk with pergolide and changes in clinical practice after label change: a survey among European neurologistsA Lledó, M A Dellva, I M Strombom, et al.
Pageof 1